Weight Loss Pills NZ: Costs, Options & Access

Anyone shopping for weight loss pills in New Zealand quickly runs into a confusing split: some of the most effective medications are available only by prescription and cost hundreds of dollars a month, while the only over-the-counter option costs far less but delivers modest results. With GLP-1 drugs like Wegovy and Mounjaro now approved locally but not funded by Pharmac, the choice is as much about money as it is about medicine.

Weight loss medicines approved in NZ: 6+ prescription options ·
Funded weight loss medications in NZ: 0 (none currently funded) ·
Over-the-counter weight loss pill available: Alli (orlistat 60 mg) ·
Average cost of Mounjaro per month in NZ: NZD 400–600 ·
Safe weight loss rate per week: 0.5–1 kg

Six approved medications, one pattern: the most effective options require a prescription and a significant monthly spend.

Which pill is best for weight loss?

Prescription weight loss pills in NZ

New Zealanders have six prescription options, but their effectiveness varies widely. Wegovy and Mounjaro are the heavy hitters: GLP-1 receptor agonists that can produce 16% to 23% total body weight loss, according to GoodRx. Mounjaro (tirzepatide) appears to edge out Wegovy in head-to-head data, per WellRevolution NZ (New Zealand health retailer). Older options like Contrave (naltrexone/bupropion), Duromine (phentermine), and Xenical (orlistat 120 mg) are all listed as available by Healthify NZ, but they produce more modest weight loss — typically 5–10% of body weight. None of these medications are funded by Pharmac, so patients pay full price.

Over-the-counter weight loss pills in NZ

If you don’t want a prescription, you have one regulated option: Alli (orlistat 60 mg). It’s the lower-dose version of Xenical, available on pharmacy shelves. According to GoodRx, Alli blocks about 25% of dietary fat absorption, leading to 2–3 kg extra weight loss per year compared to diet alone. Many unregulated supplements line the shelves too, but only Alli carries MedSafe approval for weight loss. The catch: it causes gastrointestinal side effects if you eat high-fat meals.

The trade-off is stark: high efficacy costs hundreds a month; low efficacy costs under $100. For someone with 5–10 kg to lose, a prescription GLP-1 may be overkill — but for major weight loss, the OTC option won’t get you there.

What this means: For anyone aiming to lose 10% or more of body weight, GLP-1s are the clear first-line choice—but the monthly bill can shock. The OTC path limits your loss potential.

What is the alternative to Ozempic in New Zealand?

Wegovy vs Ozempic for weight loss

Ozempic (semaglutide) is approved in New Zealand for type 2 diabetes, not weight loss. Healthify NZ states it is “currently not marketed in Aotearoa New Zealand for weight loss.” Its sister drug, Wegovy, was approved specifically for weight management by Medsafe in May 2026. Wegovy uses the same active ingredient but at higher doses and with a weight loss indication. Both are GLP-1 agonists, but Wegovy is the designated alternative. WellRevolution NZ reports Wegovy starting at $429.99 per month.

Mounjaro as an alternative

Mounjaro (tirzepatide) is a dual GIP/GLP-1 agonist approved for weight loss in NZ from May 2026. It often produces slightly greater weight loss than Wegovy in trials. Pricing per MacMurray Health (a New Zealand medical practice) reaches $875.99 per month at the maximum 15 mg weekly dose. WellRevolution confirms stock arriving in New Zealand pharmacies, with entry pricing from $429.99.

The pattern: Mounjaro offers the highest average weight loss in NZ, but it’s also the most expensive. Wegovy is slightly cheaper and still highly effective. Both remain unfunded, so the choice comes down to budget and tolerance for injections.

Can you get Ozempic in NZ?

Ozempic availability in New Zealand

Yes, Ozempic is available by prescription in New Zealand—but only for type 2 diabetes. Healthify NZ confirms it is not approved for weight loss, though doctors may prescribe it off-label. Off-label use means you pay full price and Pharmac’s subsidy protections don’t apply.

Ozempic prescription requirements

To get Ozempic in NZ, you need a GP or specialist prescription for type 2 diabetes. For weight loss specifically, you’d need a different drug (Wegovy, Mounjaro, Contrave, etc.). Off-label prescribing is legal but less common—many GPs now refer patients to the approved weight-loss agents instead.

The trade-off: Using Ozempic off-label for weight loss skirts the indication but is possible. However, you risk supply shortages (diabetes patients need priority) and you won’t get Pharmac subsidy. Wegovy or Mounjaro are the proper channels.

What is the most effective weight loss pill over-the-counter?

Alli (orlistat 60 mg) effectiveness

Alli is the only MedSafe-approved over-the-counter weight loss pill in New Zealand. It contains 60 mg of orlistat, which blocks about 25% of fat from meals. According to GoodRx, users can expect 2–3 kg extra weight loss per year versus diet alone. That’s modest but measurable. The key to making Alli work is a low-fat diet—otherwise you’ll experience oily spotting and urgency.

Other OTC weight loss supplements

Shelves are packed with supplements claiming to boost metabolism or burn fat—green tea extract, raspberry ketones, garcinia cambogia—but none have MedSafe approval for weight loss. Healthify NZ does not list any of these as effective weight loss medicines. The only evidence-backed OTC option remains Alli.

Why this matters: If you’re considering an OTC pill without a prescription, Alli is your sole evidence-based choice. Everything else is an unregulated supplement with no proven efficacy. For real weight loss, you’ll likely need a prescription.

How much is Mounjaro NZ?

Mounjaro cost at Chemist Warehouse Auckland

Mounjaro pricing varies by dose and pharmacy. MacMurray Health lists the maximum 15 mg weekly dose at $875.99 per month. Starter doses are cheaper—typically $429 to $600 per month, according to WellRevolution NZ. Chemist Warehouse Auckland and other pharmacies now stock it, but prices may differ across locations.

Mounjaro funding status

As of May 2026, Pharmac has announced it will not fund Mounjaro or Wegovy for weight loss. That means every dose comes out of your pocket. Healthify NZ notes that no weight loss medicines are currently subsidised. If you’re on the maximum dose, you’re looking at over $10,000 per year.

The implication: Mounjaro is a powerful tool, but its cost puts it out of reach for many. Those who can afford it may lose 20+ kg over a year; those who can’t are left with older, cheaper, less effective options. Pharmac review in 2027 could change the picture—but no decisions have been announced.

Comparison: All NZ-approved weight loss pills

Seven medications, two categories, one critical difference: prescription versus OTC. Here’s how they stack up on monthly cost, expected weight loss, and accessibility.

The trade-off: The most effective drug (Mounjaro) costs 9× more than Alli per month. For someone who needs to lose 20 kg, the cheaper path simply won’t deliver—even over years. The only realistic option for major weight loss is prescription GLP-1s, and that means budgeting $400+ monthly.

Specifications at a glance

Each medication works differently. Here’s the mechanism, dosing frequency, and common side effects.

The pattern: GLP-1s are injections, require titration, and cause gastrointestinal distress early on. Orals are simpler but less potent. Side effects are universal—nausea tops the list for nearly all options.

Pros and cons: Prescription vs OTC

Timeline: Weight loss pills in NZ

• May 2026: Medsafe approves Wegovy and Mounjaro for weight loss in New Zealand (Healthify NZ)
• May 2026: Pharmac confirms neither drug will be funded (Healthify NZ)
• Mid-2026: Mounjaro stock begins arriving at NZ pharmacies (WellRevolution NZ)
• Ongoing: Contrave, Duromine, and Xenical remain prescription-only and unfunded (Healthify NZ)

The pattern: 2026 was a breakthrough year for approvals but a bust for funding. Patients now have access to world-class weight loss drugs—if they can pay.

What we know and what remains unclear

Expert perspectives

“Weight loss medicines are not funded or subsidised in Aotearoa New Zealand, meaning patients must pay the full retail price.”

– Healthify NZ (government-funded health information service)

“Mounjaro offers the highest average weight loss compared to Wegovy and Saxenda in New Zealand.”

– WellRevolution NZ (New Zealand health retailer)

Summary

New Zealanders now have access to world-class weight loss medications—Mounjaro and Wegovy—that can produce 16–23% body weight loss. But every dose comes at full retail price, with monthly costs ranging from $430 to $876. The only OTC alternative, Alli, costs under $100 but delivers just 2–3 kg per year. For anyone with significant weight to lose, the decision is not really about which pill is best: it’s about whether you can afford the monthly bill. If Pharmac does not fund these drugs in the next review, weight loss in NZ will remain a privilege of income rather than a matter of health. For the Kiwi eyeing the scales, the clear choice is to consult a GP, discuss a prescription for a GLP-1, and budget accordingly—or commit to a long, slow road with Alli.

For a comprehensive overview of prescription options and funding, consult this Weight Loss Medication NZ guide.

Frequently asked questions

Related reading: Fatty Liver Symptoms in Females: Warning Signs & Treatment — Low Blood Pressure Symptoms: Causes & Emergency Signs